Senior Expert Accounting Standards IFRS (all genders)

We are currently seeking for our Headquarter in Hamburg a highly motivated and dedicated Senior Expert Accounting Standards IFRS (all genders) Full-time and permanent Responsibilities:

• Monitor IFRS /DRS and regulatory developments, assess their impact, and proactively prepare the organization for upcoming changes in accounting standards
• Drive the development and continuous improvement of Group IFRS Accounting Policies, including drafting, updating, and communicating internal guidelines
• Act as a subject-matter expert for complex accounting questions, supporting subsidiaries, business units, and Group functions
• Support the preparation of Consolidated financial statements, including judgmental areas, disclosures, and audit-related topics, and ensure appropriateness of Notes and Management report according to IFRS and DRS
• Lead Projects to implement new standards and regulations according to IFRS and DRS/HGB with effect on Group Financial Statements
• Provide training and knowledge-sharing sessions to elevate IFRS accounting expertise across the organization
• Collaborate closely with external auditors, ensuring smooth audit processes and high-quality documentation
• Contribute to cross‑functional projects, such as M&A transactions, new business models, system implementations, and process harmonization

Required qualifications:

• Successful university degree (or equivalent) in business administration, advanced studies in international accounting, group accounting or auditing
• 5+ years of experience in accounting, auditing, or financial reporting, ideally within a Big Four firm or a publicly listed company
• Deep, demonstrable expertise in IFRS and strong analytical skills for complex accounting topics
• Experience in Pharma/Biotech is a strong advantage
• Proactive mindset, high attention to detail, and the ability to work independently in a dynamic environment
• Strong communication skills, with the ability to translate technical accounting issues into clear, actionable guidance
• Fluent in German and English

Further ideal qualifications:

• Experience in Technical Accounting department of a Listed Company
• Experience in Big Four firm
• Experience of working in an international environment, ideally in Pharma/Biotech

Our offer:

• A permanent position within a vigorous and exciting professional environment promoted by an open culture, a spirit of community and continuous improvement
• A diverse, international workforce with a dynamic working environment that fosters creativity, innovation, and teamwork
• 30 days annual holiday
• monthly allowance for public transportation
• in‑house canteen
• Capital forming benefits
• flexible working hours
• holiday pay
• annual bonus depending on performance

FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.

ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.

Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first‑in‑class and best‑in‑class pharmaceutical products. Evotec leverages this “Data-driven R&D Autobahn to Cures” for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world‑leading co‑owned pipeline for innovative therapeutics and has to‑date established a portfolio of more than 200 proprietary and co‑owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 5,000 highly qualified people. The Company’s 17 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence.